We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Download Mobile App





Semen Analysis Portfolio with Two New Products Featured at AACC 2016

By LabMedica International staff writers
Posted on 04 Aug 2016
Print article
Image: The SQA-V Gold with V-Sperm Gold (Photo courtesy of Medical Electronic Systems).
Image: The SQA-V Gold with V-Sperm Gold (Photo courtesy of Medical Electronic Systems).
Showcasing at the AACC Annual Meeting & Clinical Lab Expo (July 31 - August 4; Philadelphia, PA, USA) is a state-of-the-art automated semen analysis system and a wide variety of sperm evaluation kits and tools for manual as well as computer-aided semen analysis.

Medical Electronic Systems (MES; Los Angeles, CA, USA, and Caesarea, Israel) will be showcasing their SQA-VISION as well as two newly released products – QwikCheck Pre-Stained Morphology slides and a Linearity and Precision kit – that supplement MES’s comprehensive line of semen analysis solutions.

The QwikCheck Pre-Stained Morphology slides are designed for rapid staining of spermatozoa for detailed morphology assessment. Each slide is coated with a dried layer of staining media that sperm will absorb on contact. The product is designed for SQA-VISION Automated Sperm Quality Analyzers and microscopic analysis. They can be used to differentiate normal sperm cells from sperm cells with abnormal heads, midpieces, principle pieces, and excess residual cytoplasm. They can also be used for the classification of WBCs and pinheads.

The QwikCheck Beads Precision and Linearity Kit is designed as a semi-annual validation tool for SQA-V and SQA-VISION sperm quality analyzers. It can be used to validate linearity, precision, and concentration accuracy per the CLIA Method Validation Regulations (CLIA Final Rules Manual, 2004, ISBN 1-886958-20-3).

Related Links:
Medical Electronic Systems

Gold Supplier
BMP Whole Blood Analyzer
GEM Premier ChemSTAT
New
Electrolyte Analyzer
CARELYTE A-Series
New
Chemiluminescence Analyzer
DZ-Lite 3000 Plus
New
Gold Supplier
Automatic Biochemistry Analyzer
Biossays C8

Print article

Channels

Clinical Chem.

view channel
Image: The analysis pipeline used to investigate associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer’s disease (Photo courtesy of University College London)

Lipid Measurements Show Potential as Alzheimer’s Disease Biomarkers

Brain changes accompanying ageing are varied and can include pathologies that lead to cognitive impairment, the commonest of which is Alzheimer’s disease (AD). Identifying blood-based signatures of brain... Read more

Molecular Diagnostics

view channel
Image: This image depicts a DNA molecule that is methylated on both strands on the center cytosine. DNA methylation plays an important role for epigenetic gene regulation in development and cancer (Photo courtesy of Wikimedia Commons)

Study Supports Use of Methylated DNA Biomarkers for Cancer Diagnosis and Prognosis

A recent study added weight to the theory that methylated DNA biomarkers could be used for cancer diagnosis and prognosis. Methylation is a biological process by which methyl groups are added to a DNA molecule.... Read more

Hematology

view channel
Image: Standard test for multiple myeloma provides clues of a rare, more deadly type (Photo courtesy of Pexels)

Standard Blood Cancer Test Provides Clues of Rare IgD Multiple Myeloma

IgD myeloma accounts for about 1% of common blood cancer multiple myeloma and has a worse prognosis. Specific testing for IgD myeloma is available at a handful of reference labs across the US, but takes... Read more

Industry

view channel
Image: QIAGEN has acquired a majority stake in enzymes provider BLIRT S.A. (Photo courtesy of QIAGEN)

Qiagen Acquires Enzymes Provider Blirt to Strengthen Sample Technologies Business

QIAGEN N.V. (Venlo, Netherlands) has signed agreements to acquire a 96% majority ownership stake in BLIRT S.A. (Gdansk, Poland), a manufacturer of recombinant enzymes for the life science industry.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.